Dr. Ankur Bahl is an eminent and internationally recognized Medical Oncologist and Hemato-Oncologist with over 20 years of clinical excellence in advanced cancer therapies. He currently serves as Senior Director of Medical Oncology and Hematology at Fortis Memorial Research Institute (FMRI), Gurugram.
He completed his MBBS and MD in Internal Medicine from Maulana Azad Medical College (MAMC), New Delhi. He then pursued super-specialization (DM) in Medical Oncology at the country's apex medical institute, the All India Institute of Medical Sciences (AIIMS), New Delhi. Dr. Bahl has also completed certification in Medical Oncology from the prestigious European Society for Medical Oncology (ESMO).
Dr. Bahl is celebrated for his expertise in precision oncology, next-generation sequencing (NGS)-driven targeted therapies, and breakthrough checkpoint inhibitor immunotherapy protocols. He has designed and managed systemic cancer therapy programs for thousands of patients across India, Africa, Central Asia, and the Middle East.
His clinical practice focuses on solid tumors (including lung cancer, breast cancer, colorectal and GI cancers, head and neck cancers, and gynecological malignancies) as well as hematological malignancies such as acute and chronic leukemias, lymphomas, multiple myeloma, and supportive care for stem cell transplantations.
Find answers to common questions about Dr. Ankur Bahl, cancer chemotherapy, targeted therapies, appointment scheduling, and services for international patients.
